Background: Lack of enteral stimulation during parenteral nutrition (PN) impairs mucosal immunity. Bombesin (BBS), a gastrin-releasing peptide analogue, reverses PN-induced defects in acquired immunity. Paneth cells produce antimicrobial peptides (AMPs) of innate immunity for release after cholinergic stimulation. Objective: Determine if BBS restores AMPs and bactericidal function during PN. Methods: Intravenously cannulated male ICR mice were randomized to Chow, PN, or PN+BBS (15 μg 3 times daily, n = 7 per group) for 5 days. Ileum was analyzed for AMPs (Protein: sPLA 2 by fluorescence, lysozyme and RegIII-γ by western andcryptdin-4 by ELISA; mRNA: all by RT-PCR). Cholinergic stimulated (100 μM bethanechol) ileal specimens assessed Pseudomonas bactericidal activity. Ileum (Chow: n = 7; PN: n = 9; PN+BBS: n = 8) was assessed for Escherichia coli invasion in ex-vivo culture. Results: PN significantly decreased most AMPs versus Chow while BBS maintained Chow levels (sPLA 2 : Chow: 107 + 14 * , PN: 44.6 + 7.2, PN+BBS: 78.7 + 13.4 * Fl/min/μL/total protein; Lysozyme: Chow: 63.9 + 11.9 * , PN: 26.8 + 6.2; PN+BBS: 64.9 + 13.8 * lysozyme/total protein; RegIII-γ : Chow: 51.5 + 10. 
altered inflammatory responses. 1, 2 Enteral feeding reduces this infectious risk. [3] [4] [5] [6] [7] The reason for this PN-induced vulnerability seems at least, in part, related to aberrations in the adaptive and innate mucosal immune systems resulting from decreased enteral stimulation. [8] [9] [10] [11] For the past 15 years, our laboratory focused on the effects of PN on adaptive (acquired) mucosal immunity whereby antigenspecific IgA antibodies are produced in the lamina propria, transported into the gastrointestinal lumen, and bind bacteria to prevent their mucosal attachment and subsequent invasion. [12] [13] [14] [15] PN with lack of enteral stimulation negatively affects numerous components of intestinal and extraintestinal (ie, respiratory) adaptive immunity including decreases in gastrointestinal-associated lymphoid tissue (GALT) size; Peyer patch, lamina propria, pulmonary, and salivary gland lymphocyte cellularity; GALT lymphocyte attractant and adhesion molecules, [16] [17] [18] and small intestinal and Peyer patch chemokines 19 ; lamina propria IgA-stimulating Th2 cytokines 20 ; and the mucosal IgA transport protein, pIgR (polymeric immunoglobulin receptor), 21, 22 ( Table 1) . [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Together, these PN-induced changes reduce secretory IgA (sIgA) at multiple mucosal surfaces, impairing IgA-mediated mucosal immunity. The functional impact includes loss of antiviral and antibacterial immunity experimentally and provides a cogent explanation for the increase in pneumonia documented in PN-fed patients.
Recent work shows that PN with lack of enteral stimulation exerts deleterious effects upon innate immunity as well. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] Paneth cells located in the crypts of Lieberkühn in the small intestine and goblet cells scattered throughout the intestinal villi are the main effector cells of innate immunity. Paneth cells produce, store, and secrete antimicrobial peptides (AMPs) including secretory phospholipase A2 (sPLA 2 ), lysozymes, regenerating islet-derived protein 3 gamma (RegIII-γ ), and α-defensins (known as cryptdins in mice), among others. 46 These AMPs are naturally occurring antibiotics that provide critical local bactericidal activity. Once released, they concentrate in the goblet cell mucus layer of the gastrointestinal tract, similar to sIgA, where they interact with intestinal bacteria, preventing mucosal attachment and invasion. PN with lack of enteral stimulation reduces the intracellular and intraluminal levels of these antibacterial molecules and the size of the mucus layer. The functional effects of these innate immune aberrations are evident experimentally, as PN-treated mice demonstrate decreased bactericidal activity of Paneth cell secretions and increased vulnerability to enteric invasion by pathogenic bacteria. Survival after bacterial challenge
Summary of current published data. All values are statistically significant (P < 0.05).
IgA, immunoglobulin A; pIgR, polymeric immunoglobulin receptor.
of water and electrolytes. 49 The ENS also influences mucosal immunity through neuropeptides, which affect the proliferation, differentiation, and function of immune cells and prevent PN-induced defects in mucosal immunity in murine models. 50, 51 Exogenous administration of bombesin (BBS), a gastrin-releasing peptide analogue, experimentally reverses PN-induced defects in gastrointestinal and respiratory adaptive mucosal immunity. It abrogates many of the PN-induced immune defects and preserves established immunity to viral and bacterial pneumonia otherwise lost with PN in murine models (Table 1) .
This study examines the role and importance of the ENS and autonomic nervous system on the integrity of innate mucosal immunity. This work examines the effect of neuropeptides on Paneth cell products applying functional outcomes including bactericidal activity of intestinal secretions and mucosal resistance to bacterial enteroinvasion during PN, both with and without BBS treatment. We hypothesized that administration of the ENS neuropeptide, BBS, during PN would restore the tissue and luminal levels of innate immune AMPs. We also hypothesized that functional defects in bactericidal activity and mucosal resistance to bacterial invasion caused by PN with lack of enteral stimulation would be restored by this exogenous neuropeptide administration.
MATERIALS AND METHODS Animals
All experimental protocols were approved by the Animal Care and Use Committee of the University of Wisconsin-Madison and Middleton Veterans Administration Hospital, Madison, WI. Male ICR (Institute of Cancer Research; Harlan, Indianapolis, IN) mice were used for experiments. Mice were housed in an American Association for Accreditation of Laboratory Animal Care-accredited facility with controlled temperature, humidity, and light cycle (12-hour light/12-hour dark). Mice were acclimatized for 1 week while housed 5 per covered/filtered box and fed a standard mouse chow (Rodent Diet 5001; LabDiet, PMI Nutrition International, St. Louis, MO) and water ad libitum before experiment protocol entry. After entry into the study protocol, mice were individually housed in metal metabolism cages with wire grid floors to eliminate coprophagia.
Surgical Procedure
Mice were anesthetized for surgical central catheter placement with an intraperitoneal injection of a mixture of ketamine chloride (100 mg/kg) and acepromazine maleate (10 mg/kg) and weighed. A silicone rubber catheter (0.012-in ID by 0.025-in OD; Helix Medical Inc, Carpinteria, CA) was inserted into the vena cava through the right external jugular vein. The distal end of the catheter was tunneled subcutaneously and exited the midpoint of the tail. Mice were partially immobilized by tail restraint after this procedure to protect the catheter during infusion. This infusion technique in the mouse has been demonstrated to be an acceptable method of nutritional support, and this method does not produce physical or biochemical evidence of stress.
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Feeding Protocols
Four groups of 6-to 8-week-old mice were randomized to diets of Chow, PN, or PN + BBS, with 6 to 10 mice per diet in each group. After catheterization, mice were connected to infusion pumps and recovered for 2 days while receiving 4 mL of 0.9% sodium chloride per day in addition to chow and water ad libitum. As previously described, this recovery period was chosen because prior work demonstrates that after 2 days, serum cytokines, corticosteroid levels, and IgA secretion induced by surgical stress return to baseline and animals in all groups resume oral intake in normal amounts. After this recovery period, experimental diets were initiated.
Chow-fed mice continued to receive 4 mL of 0.9% sodium chloride per day with chow and water ad libitum throughout the study. PN-and PN + BBS-fed mice received PN solution at 4 mL/d (day 1), 7 mL/d (day 2), and 10 mL/d (days 3-5) because a graded infusion period is necessary for the mice to adapt to PN glucose and fluid loads. The PN solution contains 6.0% amino acids, 35.6% dextrose, electrolytes, and multivitamins for a total of 1440 kcal/L and a nonprotein calorie/nitrogen ratio of 128:1. This formula meets the calculated nutrient requirements of mice weighing 25 to 30 g and was metabolically scaled to the average weight of mice in this experiment. 53 In addition, each group received intravenous injections via the catheter 3 times a day (at 07:00, 15:00, and 23:00 hours). Chowand PN-fed mice received 100 μL of vehicle 0.9% sodium chloride, whereas the PN + BBS group received 15 μg of BBS (Sigma, St Louis, MO) dissolved in 100 μL of 0.9% sodium chloride.
Sample Collection
After 5 days of experimental treatment (7 days postcatheterization), animals were anesthetized again by intraperitoneal injection of a mixture of ketamine hydrochloride (100 mg/kg) and acepromazine maleate (10 mg/kg), weighed, and exsanguinated via left axillary artery transection. The small intestine was removed and mesenteric fat, lymph nodes, Peyer patches, and external vasculature were dissected away. A cold solution of 20 mL of calcium-magnesium-free Hanks' balanced salt solution (CMF-HBSS; Bio Whittaker, Walkersville, MD) was flushed through the intestinal lumen (pylorus to terminal ileum) and collected. These intestinal lumen wash specimens were kept on ice until they were centrifuged at 2000 × g for 10 minutes at 4
• C. A 1-mL solution of supernate was frozen at −80 • C for future protein analysis.
After washing, small intestine tissue samples were taken as 2-cm segments of distal ileum that were fixed in 4% paraformaldehyde for immunohistochemistry (IHC), snap frozen in RNAlater, or snap frozen with liquid nitrogen and stored at −80
• C until processing for -polymerase chain reaction (PCR) and tissue protein analysis. Additional 2-cm ileal segments were opened longitudinally and either placed in 24-well multidishes (Nunc, Roskilde, Denmark), containing 1 mL of CMF-HBSS on ice, or placed in cold RPMI solution for imminent ex vivo intestinal segment culture. Segments placed in the 24-well multidishes were randomized to incubate with either saline or 100 μM bethanechol (Cat# C5259; Sigma) for 1 hour at 37
• C. Secretions were filtered through 0. 
Immunohistochemistry
To visually confirm the location and semiquantitatively assess concentrations of sPLA 2 , lysozyme, and RegIII-γ in Paneth cells, we performed IHC on ileum segments from each treatment group (Chow, PN, PN + BBS). After overnight fixation in 4% paraformaldehyde, samples were transferred to 70% ethanol and stored at 4
• C until processing. Samples were processed with a Tissue-Tek V.I.P. tissue processor with the following wash steps: 70% EtOH, 45 minutes; 80% EtOH, 45 minutes; 95% EtOH, 2× 1 hour; 100% EtOH, 2× 1 hour; xylene, 2× 1 hour; paraffin MP 60
• C (Surgipath, Richmond, IL), 2× 45 minutes; paraffin, 2× 1 hour. Samples were then embedded in paraffin, sectioned at 5 μm with a microtome, and placed on adhesive-coated slides (White Aminosilane, Newcomer Supply, Madison, WI). Slides were deparaffinized in xylene and rehydrated in graded alcohol baths. Antigen retrieval was performed by boiling slides in a 10-mmol/L sodium citrate bath (pH 6.0). Slides were then blocked with 10% bovine serum albumin (BSA)-PBS for 1 hour. Samples were incubated with primary antibody for sPLA 2 (1:200, sc-14468, goat polyclonal IgG; Santa Cruz Biotechnology), lysozyme (1:400, ab108508, rat monoclonal IgG; Abcam), or RegIII-γ (1:500, PA5-25517, rabbit polyclonal IgG; Thermo Scientific) overnight in 1% BSA-PBS at 4
• C in a humidified chamber. Remaining solutions were tapped off and samples were incubated with respective secondary antibodies in 1% BSA-PBS (1:1000, Alexa Fluor 594; Invitrogen, Grand Island, NY). Slides were imaged after DAPI treatment (P36935; Invitrogen) and cover placement.
Reverse Transcription-Polymerase Chain Reaction
38
RNA Extraction
A 2-cm segment of distal ileum was collected and snap frozen in RNAlater (Cat # R0901; Sigma) and stored at −80
• C until further use. The SV Total RNA Isolation System (Cat# Z3100; Promega) was used to isolate RNA from tissue samples following manufacturer instructions. A nanodrop spectrometer (Thermo Scientific) was used to confirm RNA samples were pure and of adequate concentration.
Reverse Transcription
After RNA isolation, cDNA was obtained using ImPromII Reverse Transcription System (Cat# A3800; Promega) following manufacturer-guided instructions.
Polymerase Chain Reaction
Specific primers were designed for sPLA 2 , lysozyme, RegIII-γ , and cryptdin-4 ( Table 2 ). All reactions were run with 1 μL of cDNA and a β-actin control. PCR was performed using recombinant Taq DNA polymerase (Cat# 10342-020; Invitrogen). PCRs were assembled in a DNA-free environment and contained 10 μL of 10× PCR buffer, 3 μL of 50 mM MgCl 2 , 2 μL of 10 mM dNTP (deoxynucleoside triphosphate) mixture, 1 unit of recombinant Taq DNA polymerase, 1 μM of each primer, and 1 μL of cDNA each. The samples were amplified in a Hybaid PCR express system (Middlesex, UK) with the following program: initial denaturation at 94
• C for 3 minutes, 25 thermal cycles of 94
• C for 1 minute, 56
• C for 30 seconds and 72
• C for 45 seconds, with a final extension at 72
• C for 10 minutes. The size and quantity of PCR products were confirmed by analysis on 3% agarose gel (weight/volume) electrophoresis, followed by staining with ethidium bromide. (sPLA 2 ) 36,37,54
Fluorescent Assay
Fluorescent assay for sPLA 2 activity was performed as previously described by Tsao et al, 54 with modification to substrate preparation as previously described. In brief, substrate was prepared by mixing 10 μL of Bis-BODipy FL C11-PN (Molecular Probes, Eugene, OR) fluorescently labeled probe in a 1-mL aliquot of phosphatidylglycerol (Sigma, St Louis, MO) dissolved in chloroform (2 mg/mL) and evaporated under nitrogen. Substrate was dissolved in 100% ethanol, which is stable for storage for 1 month at −20
• C. Assay reaction mixture was subsequently prepared in glass culture tubes on ice with 10 μL of the stored substrate ethanol solution ( , which contains ample EGTA for complete calcium sequestration. The reaction curve was fit to a second-order polynomial equation after all reactions reached equilibrium temperature. The first-degree coefficient was taken as the initial rate of reaction (expressed as change in FL/min/μL sample). Blank wells were used to identify background activity coefficient rates.
Western Blotting (Lysozyme and RegIII-γ )
The amount of solubilized protein from each tissue homogenate was determined using the Bradford assay method. In sum, 40 μg of tissue homogenate protein, 15 μL of luminal wash fluid, or 15 μL of bethanechol-stimulated secretions were used for Western blotting. Samples were denatured at 95
• C for 5 minutes with sodium dodecylsulfate and β-mercaptoethanol and separated using 10% agarose gels by electrophoresis at 150 V for 45 minutes at room temperature. Proteins were transferred to polyvinylidene fluoride membrane using Tris-glycine buffer plus 20% methanol at 80 V for 40 minutes at 4
• C. Membranes were blocked with 5% nonfat dry milk prepared in TBS-Tween for 1 hour at room temperature with constant agitation. Membranes were then incubated with primary antibody, monoclonal lysozyme (ab108508; Abcam) diluted 1:5000, and rabbit polyclonal RegIII-γ (PA5-25517; Thermo Scientific) diluted 1:250 overnight at 4
• C with constant agitation. Membranes were then washed and incubated with secondary antibody and goat antirabbit HRP diluted 1:20,000 for lysozyme and 1:15,000 for RegIII-γ for 1 hour at room temperature with constant agitation. After washing, membranes were incubated with HRP substrate (Super Signal West Femto maximum sensitivity substrate; Pierce, Rockford, IL) for 5 minutes, and bands were detected using ImageQuant4000 (GE Healthcare). Molecular weight bands of 14 kDa were used to verify lysozyme, and molecular weight bands of 18 kDa were used to verify RegIII-γ size. NIH ImageJ software was used to determine relative concentrations with densitometry.
Enzyme-Linked Immunosorbent Assay (Cryptdin-4)
Mouse neutrophil defensin 4 (DEFA4) ELISA Kit (Cat# MBS904696; Cusabio) was used to determine cryptdin-4 protein levels in ileal tissue homogenates and ileal wash fluid following manufacturer-provided instructions. Briefly, precoated manufacturerprovided plates were incubated for 2 hours at 37
• C with 100 μL of standards, 100 μL of a 1:20 dilution of homogenized mouse ileal samples, and 100 μL of ileal wash fluid samples (neat). After this incubation, liquid was removed from the wells and 100 μL of Biotin-antibody (1×) was added to each well and incubated at 37
• C for 1 hour. Plates were then washed and incubated with 100 μL of HRP-avidin at 37
• C for 1 hour. Plates were again washed and then incubated with 90 μL of TMB substrate for 15 minutes at 37
• C before the reaction was stopped with 50 μL of Stop Solution. Plates were read at 450 nm using Molecular Devices Vmax kinetic microplate reader within 5 minutes of stopping the reaction.
Bacterial Preparation and Bactericidal Assay 38
To determine bactericidal activity in small intestinal tissue samples obtained from the 3 diet treatment groups, Pseudomonas aeruginosa was cultured for 24 hours at 37
• C in lysogeny broth (LB) (Fisher Scientific, Fair Lawn, NJ). Bacteria were then washed and suspended in CMF-HBSS as previously described, and bacterial suspension concentration was adjusted to 2 × 10 3 colony forming units (CFUs)/mL in CMF-HBSS. To evaluate bactericidal activity, 10 μL (∼100 CFUs) of bacterial suspension was added to both 200 μL of culture media containing bethanechol-stimulated tissue and tissue stimulated with CMF-HBSS (controls). Samples were incubated at 37
• C for 1 hour. Bacterial survival was assessed by plating bacteria incubated with bethanechol-stimulated secretions in duplicate on LB agar plates (Fisher Scientific, Pittsburg, PA) under aerobic conditions at 37
• C overnight. CFUs were counted and normalized to paired controls, and results were expressed as bactericidal activity as measured by the reduction in percent surviving CFUs.
Bacterial Preparation and Ex Vivo Intestinal Segment Culture
38,55
Escherichia coli 5011-Lux containing ampicillin resistance was grown in LB plus ampicillin (1:1000) for 24 hours at 37
• C with 5% CO 2 and passed to new LB to grow for another 24 hours at 37
• C with 5% CO 2 to increase virulence. Bacteria were washed and suspended in 1 mL of DPBS at 4
• C as a bacterial stock solution as previously described. A spectrophotometer (DU640B; Beckman) at 450-nm wavelength was used to determine bacterial concentration and the stock solution was adjusted to 1 × 10 8 CFUs/mL in RPMI plus ampicillin (100 μg/mL), based on previously established growth curves. Intestinal segments placed on a sterile surface were covered in a light layer of RPMI and opened longitudinally apical side up. Plastic rings (9-mm aperture) were lightly coated on one side with tissue glue (Dermabond; Ethicon, Cornelia, GA) and placed on the mucosal side of the intestinal segment. A second plastic ring was lightly coated with tissue glue and placed on the serosal side of the intestinal segment to sandwich the segment between the 2 discs. A light layer of tissue glue was then applied to the bottom of the serosal disc, and the complex was lowered into a cell culture insert (Cat# 3292, 3.0-μm pore, 12-well format; BD Bioscience) mucosal side up. Gentle pressure was applied to the discs to ensure adherence of the bottom tissue disc to the cell culture insert. Cell culture inserts were placed into 12-well plates.
A 400-μL adjusted bacterial stock solution in RMPI plus ampicillin was added to each insert and incubated for 1 hour at 37
• C. Bacterial inoculum was removed and wells were gently rinsed 3 times with 700 μL of DPBS. A solution of 600-μL RPMI plus gentamicin (100 μg/mL) was added to each well, and samples were incubated at 37
• C for 1 hour. E. coli 5011-Lux is susceptible to gentamicin, and this incubation kills any extracellular bacteria in the wells. The RPMI plus gentamicin solution was removed, and wells were again washed as previously. A 500 μL solution of 0.1% Triton-X in PBS was added to each insert, and plates were agitated on an orbital shaker (175 rpm; New Brunswick Scientific Classic Series C1 Shaker) for 30 minutes at 37
• C to lyse cells. Serial dilutions (10 3 -10 5 ) of cell lysate in DPBS were plated in duplicate on LB + ampicillin agar plates and grown for 18 hours at 37
• C with 5% CO 2 . Enteroinvasion was assessed by counting CFUs grown from cell lysate.
Statistical Analysis
All values are expressed as means ± standard error of the mean. Statistical analysis was performed by analysis of variance, followed by the Fisher protected least significant difference post hoc test or the Student t test. Differences of P < 0.05 were considered statistically significant. All statistical calculations were performed with StatView (Abacus Concepts, Berkeley, CA). Bactericidal activity was measured by normalizing treatment group CFUs to the control group CFUs using pair analysis in each respective experiment. Treatment group CFUs were compared using analysis of variance.
RESULTS
The preexperiment weights of mice in all groups were similar. There were no differences in body weight changes between treatment groups (P > 0.05) ( Table 3) .
sPLA 2
Representative IHC is shown in Figures 1A-C . PN caused a significant decrease in sPLA 2 mRNA transcription compared with Chow (P = 0.02). PN + BBS significantly increased sPLA 2 mRNA transcription compared with PN alone (P = 0.02) to a level similar to chow-fed mice (P = 0.97) (Fig. 2A) . PN significantly decreased sPLA 2 fluorescent activity in tissue, luminal fluid, and bethanechol-stimulated secretions compared with chow-fed mice (P = 0.002, P = 0.02, and P = 0.01, respectively) (Figs. 2B-D) . The values given are mean ± SEM. There are no statistically significant differences among groups (P > 0.05). The addition of BBS to PN restored tissue levels of sPLA 2 activity toward Chow levels (P = 0.049) (Fig. 2B) ; however, luminal sPLA 2 activity remained significantly decreased with PN + BBS compared with Chow (P = 0.002) at levels similar to PN-fed mice (Fig. 2C) . Bethanechol-stimulated secretion of sPLA 2 increased after PN + BBS feeding compared with PN, but this increase did not reach statistical significance (P = 0.06) (Fig. 2D ).
Lysozyme
Representative IHC is shown in Figures 1D-F . PN resulted in a significant decrease in lysozyme mRNA transcription compared with Chow (P = 0.008). PN + BBS significantly increased lysozyme mRNA transcription compared with PN alone (P = 0.0002) to values not significantly different from Chow (P = 0.13) (Fig. 3A) . PN resulted in a significant decrease in tissue lysozyme protein levels compared with Chow (P = 0.02), whereas PN + BBS significantly improved tissue lysozyme protein levels from PN levels (P = 0.01) to Chow levels (Fig. 3B) . Luminal protein levels of lysozyme significantly decreased with PN (P = 0.008). Luminal protein levels of lysozyme increased with PN + BBS, but this increase failed to reach statistical significance (P = 0.12) (Fig. 3C) . Lysozyme protein levels in tissue secretions after bethanechol stimulation significantly decreased with PN compared with chow feeding (P = 0.015) but normalized to Chow levels with the addition of BBS to PN (P = 0.0003) (Fig. 3D) . levels tended to decrease with PN after bethanechol stimulation of isolated intestinal segments and trend back toward Chow levels with the addition of BBS; however, these changes were not statistically significant (P = 0.11 and P = 0.23, respectively) (Fig. 4D ).
Cryptdin-4
PN significantly decreased cryptdin-4 mRNA transcription compared with Chow (P = 0.004). PN + BBS significantly increased cryptdin-4 mRNA transcription compared with PN alone (P = 0.03) to values not significantly different from Chow levels (P = 0.36) (Fig. 5A) . Tissue levels of cryptdin-4 were not detectible in 5 of 11 PN samples. Comparing only the 6 samples detectable for cryptdin-4 with the other groups, PN decreased tissue levels of cryptdin-4 compared with Chow but not quite to statistical significance (P = 0.07). PN + BBS significantly increased tissue cryptdin-4 protein in comparison with both PN and Chow (P = 0.0002 and P = 0.005, respectively) (Fig. 5B ). There were no significant differences in luminal levels of cryptdin-4 between groups (P > 0.05) (Fig. 5C ). Bethanechol did not stimulate cryptdin-4 release to consistently detectable levels (data not shown).
Bactericidal Activity
Functionally, PN feeding significantly decreased bactericidal activity in secretions obtained from small intestinal segments after bethanechol stimulation when compared with chow feeding (P = 0.039). The addition of BBS to PN restored bactericidal activity back to Chow levels (BBS vs Chow, P = 0.77; BBS vs PN, P = 0.017) (Fig. 6A) .
Enteroinvasion
In a model of ex vivo intestinal segment culture, PN demonstrated a significant increase in bacterial enteroinvasion when compared with chow feeding (P = 0.008). PN + BBS reduced bacterial enteroinvasion compared with PN levels; however, this result barely failed to reach statistical significance (P = 0.06) (Fig. 6B) .
DISCUSSION
PN prevents progressive protein-energy malnutrition in patients unable to be fed enterally; however, it carries an increased risk of septic and inflammatory morbidity in critically ill patients compared with enteral feeding. Although the cause of increased infectious complications and inflammation in PN-fed patients is likely multifactorial, significant changes in acquired and innate mucosal immunology remain cogent hypotheses to explain these clinical outcomes. Given that the ENS neuropeptide analogue, BBS, experimentally restores cellular and functional aspects of adaptive immunity, this work examined its effects on the innate immune system.
The surface area of adult gastrointestinal tract encompasses an area of more than 200 m 2 , making it the largest surface of the body directly in contact with the outside world. 56 The human gut contains 500 to 1000 species of bacteria, and the total number of bacteria exceed the total number of human cells 150-fold. [57] [58] [59] Normally, a symbiotic relationship exists between host and microbiome whereby the intestine provides nutrients to the bacteria whereas the bacteria aid in food digestion, nutrient absorption, and vitamin production. reduce bacterial attachment prevents mucosal invasion and subsequent infection despite the huge bacterial burden. This protection occurs through 2 basic immunologic systems. The adaptive immune system produces sIgA, which concentrates within the mucus layer to provide protection against specific bacterial antigens by binding to these bacteria and preventing invasion. 9 The innate immune system exists as a more teleologically ancient system that secretes AMPs (Table 4) . 46, [60] [61] [62] [63] [64] [65] [66] [67] [68] PN with lack of enteral stimulation impairs both systems.
To our knowledge, this is the first work examining interactions between the innate immune system and the ENS. Prior work demonstrated that Paneth cell antimicrobial peptide (sPLA 2 , lysozyme, RegIII-γ , cryptdin-4) transcription decreased with PN compared with chow feeding, which coincided with alterations in microbiome composition, 44, 69 decreased bactericidal activity of Paneth cell secretions, and increased intestinal susceptibility to enteroinvasion. 38 This study expands on those studies to confirm these findings using IHC of in situ Paneth cell granules and measurements of tissue AMP production and levels. It also examines the ability of isolated tissues to release AMPs from the tissue and provides quantitative measurement of resistance of the tissues to bacterial invasion. Although PN with lack of enteral stimulation reduced or impaired each of these variables, BSS supplementation of PN reversed most of these negative effects on the innate immune system defenses.
Paneth cells produce AMPs that constitute an integral component of the innate immune system. 70 Mice lacking Paneth cells fail to clear infectious organisms and frequently develop a lethal colitis. 71 By specifically ablating Paneth cells using a transgenic mouse model, Vaishnava et al 72 concluded that Paneth cell products limit bacterialmucosal contact and mucosal attachment by controlling the number of mucosa-associated bacteria. Paneth cells contain an extensive endoplasmic reticulum and Golgi networks ultrastructurally involved in protein production and secretion. 46, 73 They produce, store, and secrete AMPs by means of large dense core granules that are apically released into the gastrointestinal lumen and concentrate in the mucin layer. 74 This AMP production seems dependent on enteral stimulation. Starvation itself decreases the number of Paneth cell granules and distorts granule packaging and exocytosis, also reducing production of constitutively produced AMPs. 40 These effects are likely related to the lack of enteral stimulation rather than malnutrition because PN prevents malnutrition while the results of starvation and lack of enteral feeding on Paneth cells appear similar. Our results show that PN with lack of enteral stimulation decreases AMP transcription and production, which are evident in the alterations in mRNA, IHC, and tissue levels.
After determining that BBS increased AMP production and storage within the Paneth cells, we examined AMP levels within the intestinal fluid washes obtained immediately after animals were killed. Surprisingly, intestinal fluid from BBS-treated mice contained low levels of AMPs at levels similar to PN feeding. Because both IHC and tissue analysis demonstrated high levels of stored AMPs present in chow-and BBS-fed mice, we examined the functional capacity of isolated intestinal segments to release AMPs from Paneth cells. Preliminary work demonstrated very limited AMP release from isolated segments incubated with saline or PBS. Previous investigators noted that bacterial products (lipopolysaccharide or muramyl dipeptide) 75 or parasympathetic (cholinergic) stimulation 76 triggered Paneth cell degranulation in vitro and in in vivo isolated intestinal perfusion models mediated through 2 independent mechanisms: (1) KCa3.1 calcium-activated potassium channels 77 and (2) activation of muscarinic receptors 78 present on Paneth cells that result in G-protein-coupled, receptor-mediated, calcium-dependent, intracellular signal transduction. 79 Both mechanisms dynamically increase
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cytosolic calcium to result in granule secretion, a process common to many exocrine and endocrine cells. 80 In the current work, cholinergic stimulation resulted in higher AMP levels in the incubation fluid and increased bactericidal activity in both Chow and BBS groups. PN treatment resulted in significantly lower AMP levels and lower bactericidal activity, presumably due to lower AMP storage within the smaller granules and possibly reduced cholinergic response of the muscarinic receptor. Taken in toto, BBS increases AMP production of sPLA 2 and lysozyme but not their release. Secretion remains under cholinergic control.
Different mechanisms seem to control RegIII-γ release. 81 Current evidence points to inducible expression of RegIII-γ through Tolllike receptor pathways activated by bacterial products. Its expression seems dependent on MyD88 signaling, 66, 72 providing direct communication between enteric bacteria and the Paneth cells. RegIII-γ regulates bacterial association by maintaining a 50-μm zone of physical separation between the mucosal surface and bacteria. 82 The higher luminal density of RegIII-γ with PN implicates RegIII-γ release as a compensatory response by the intestinal mucosa to maintain homeostasis due to significant changes in the luminal environment. 66, 83 However, ENS activation presumably plays some role in this intesti-FIGURE 6. Functional effects of Chow, PN, and PN + BBS. Functional effect of diet on (A) bactericidal activity (Chow: n = 6; PN: n = 8; PN + BBS: n = 7) and (B) susceptibility to enteroinvasion (Chow: n = 7; PN: n = 9; PN + BBS: n = 8). Data are presented as mean ± SEM.
* P < 0.05 versus Chow; †P < 0.05 versus PN.
nal homeostasis because BBS treatment resulted in RegIII-γ levels returning to chow levels.
Cryptdin-4 protein levels were undetectable in the incubation fluid after cholinergic stimulation in all dietary groups. mRNA data are consistent with results from Hodin et al, 40 who found decreased production of constitutively expressed AMPs, including cryptdins, in a starvation model. A better method for cryptdin protein detection is necessary to further research its mechanism of production and secretion from Paneth cells.
In the final experiments of function, ex vivo intestinal segment culture allowed analysis of tissue susceptibility and resistance to bacterial enteroinvasion. Significantly greater enteroinvasion occurred with PN than with Chow, consistent with decreased AMP production and secretion. Exogenous BBS reduced enteroinvasion, barely missing statistical significance compared with PN. Although factors other than AMP production and secretion almost certainly affect this functional test, the observation that BBS failed to release AMPs from Paneth cells may play a role in the enteroinvasion experiment. Further research to test this hypothesis is currently underway.
It is not surprising that the nervous system is integrated into mucosal immunity-both acquired and innate. The gastrointestinal tract is richly innervated by both the ENS and the autonomic nervous system. The number of neurons in the ENS approximates the number of neurons within the spinal cord. 84 Approximately 2 m of nervous tissue innervate every cubic millimeter of intestinal tissue, with most nerve tissue located within 13 μm of GALT mucosa. 85, 86 The vagus nerve provides parasympathetic innervation to the upper gastrointestinal tract (through the ascending colon). 87 Vagal neurons have long preganglionic fibers that project primarily to the myenteric and submucosal plexuses where they have extensive and highly divergent arbors that allow them to synapse in or near their targets. 88 These fibers are also intricately interlaced with neurons of the ENS and can relay central input.
Primary limitations of this study reflect the inability to define intracellular mechanisms, which, for AMP production in general, are not well defined in the literature. Our data show innate immune changes with administration of BBS to PN-fed mice; however, these BBS effects may be indirect through signaling cascades. BBS is an analogue for gastrin-releasing peptide (GRP), which is normally secreted early after enteral stimulation. GRP triggers release of other peptides and hormones (ie, gastrin, cholecystokinin, etc). 48 Our previous work demonstrate that individual neuropeptides such as gastrin, cholecystokinin, and neurotensin induce direct, although more limited, effects on specific mucosal immunity. 89 With regard to the functional studies, it is likely that other AMPs are involved. Quantitatively other AMPs exist that were not measured in this study, although our prior work demonstrated that sPLA 2 seemed responsible for approximately 70% of AMP-derived antibacterial activity, 37 although others have noted variation from this number. 75 The principles defined in this work seem valid, nevertheless. Finally, this series of experiments does not isolate innate immune function so that some sIgA-based mucosal immunity and an altered mucin layer likely play a role in our functional results. 91 These primed cells distribute themselves throughout the body-in particular the lung and the liver-and generate an augmented inflammatory response to subsequent insults, resulting in hepatic and pulmonary dysfunction. Thus, as the gut barrier loses integrity and generates a host response to bacteria, the stage is set for systemic inflammation and organ dysfunction with further insults to the host. BBS may prevent this.
CONCLUSIONS
This work provides evidence for the novel use of BBS to enhance innate immune function by increasing Paneth cell AMP levels and bolstering innate defenses against enteroinvasion. Our results indicate that BBS supplementation acting as a stimulus for the ENS increases production of at least 4 AMPs: sPLA 2 , lysozyme, RegIII-γ , and cryptdin-4. Increases in tissue levels of AMPs do not translate into increases in luminal levels, their target destination; release requires cholinergic stimulation. These results suggest that PN + BBS treatment could provide the weapons to mount a defense against pathogens but need additional stimuli to release them. In vivo experiments are currently underway to test this hypothesis. Theoretically, PN feeding alone will not maintain complete innate defense even with cholinergic secretory stimuli due to limited AMP production. We conclude that ENS stimulation via specific neuropeptides enhances the innate immune system. However, the autonomic nervous system, particularly the parasympathetic nervous system, seems necessary to appropriately use the bolstered immune system against pathogenic threats.
DISCUSSANTS F. Moore (Gainesville, FL):
I have no disclosures. Twenty-five years ago, our group from Denver published the results of a prospective randomized trial demonstrating that early enteral nutrition compared with early total parenteral nutrition (TPN) reduced nosocomial infections, principally pneumonia. Three years later, Dr Kudsk in Memphis, a group independent of us, published a prospective randomized trial documenting very similar results. As a result, in the early 1990s, some surgeons began to change their practice. However, naysayers, some in this audience, dismissed this concept of early enteral nutrition because we could not provide a plausible mechanistic explanation. As a result, over the next decade, we and others focused our research to address this issue.
Of course, this is multifactorial. On one hand, TPN, especially as prescribed in the 1980s, was immunosuppressive and therefore harmful. However, the bulk of the evidence indicates that early enteral nutrition is beneficial because it maintains vital gut functions, including mucosal perfusion, motility, permeability, and immunity. Dr Kudsk's laboratory has primarily focused on characterizing a specific adaptive mucosal immune response that regulates sIgA. They have nicely shown that lack of enteral stimulation, that is, the use of TPN, causes a rapid decrease in respiratory sIgA levels and that laboratory animals then exposed to pathogens via intratracheal inoculation die of overwhelming infections. These events can be avoided by the concurrent administration of BBS. Dr Kudsk's laboratory is now studying a specific innate immune response in the gut that involves the production and release of antimicrobial peptides that exert local bactericidal activity and prevent bacterial mucosal invasion. They have nicely demonstrated downregulation of this response with TPN associated with decreased bactericidal activity and increased mucosal invasion. Most of these events can be avoided by concurrent administration of BBS.
I have several questions. You have previously shown that TPN adversely affects adaptive mucosal immunity with decreases in respiratory sIgA that provides a plausible mechanism to explain increased pneumonias seen with TPN. How does your current observation of decreased innate mucosal immunity with decreasing gut antimicrobial peptides translate into increased nosocomial infections with TPN? Are you rejuvenating the bacterial translocation hypothesis?
Which is more important in decreasing nosocomial infections, adaptive or innate immunity? What's the relevant importance of adaptive versus innate immunity after major trauma and surgery? Would you have seen different results in previously injured mice?
Finally, the Glue Grant investigators recently wrote a provocative manuscript that concluded that the mice models that we use to study trauma failed to recapitulate the human condition. So how do your current observations made in healthy mice translate to my critically ill trauma patients?
I would like to congratulate Dr Kudsk and his team for offering yet again intriguing experimental data explaining how the lack of enteral feeding, that is, the use of TPN, adversely affects mucosal immunity, setting the stage for nosocomial infections, and demonstrating that this can be prevented by concurrent administration of BBS.
Response From K.A. Kudsk:
Back when Chris Ellison and I were residents at Ohio State, we were well versed in the response to eating in terms of hormonal response throughout the gastrointestinal tract. A lot of that information is unknown by current residents. They struggle through those explanations. But who would have guessed at that time that feeding via the gastrointestinal tract upregulates the immunity that lines the gastrointestinal tract? That's really what we are showing.
How good is the animal model? We have investigated that and written a review article looking at the similarities between the mouse and the human.
The mouse model is one of the few models in which 90% of the antibody is directly transported across the mucosa by the same system as a human, much different than other animal models. Mice use the same cytokines. And we have shown that there's atrophy that occurs when you don't feed via the gastrointestinal tract.
A former colleague of mine who was in my laboratory, Dr. Fukatsu took a large group of patients who were given either intravenous feeding or fed enterally up until the time of a hemicolectomy. They looked at the immune cells within the distal ileum and confirmed exactly what we have shown within the mouse, a reduction in IgA-producing cells and a reduction of T cells and a shift away from the T-4 type of cells that stimulate IgA production.
I think adaptive immunity is protective primarily in the lung. Defensins don't play much of a role there, and it's the loss of IgAmediated immunity that allows bacteria, particularly in someone who is intubated, to be continually insulted with loss of defense.
We have studied this in stress models. By collecting bronchoalveolar lavage (BAL) samples from trauma patients and comparing them with patients who were having elective surgery, we noted that the injured patient flooded the airway with increases in epithelial fluid and IgA, compared with patients who were undergoing elective surgery.
We were surprised by that, took it back into the animal model, and found that the exact thing happened within the mouse. When we looked at the cytokine profiles with the human BAL samples and the mouse IgA samples, they were almost identical as well.
There's only certain numbers of these experiments that can be done in mice and humans, but every comparison that's been completed so far shows that the same thing happens in the mouse and in humans. Interestingly, when you parenterally feed animals and then injure them, you completely destroy the upregulation and IgA protection.
So my feeling is that IgA protects against pneumonia. These innate immune effects occurr within the gastrointestinal tract increasing inflammation within the intestine through the same mechanism that your brother (Gene Moore, MD) has studied with sPLA 2 and priming of neutrophils; that has more of an effect upon multiple organ dysfunction. 
